Galloylated Flavonol Glycosides from Leaves of Calliandra tergemina with Antibacterial Activities against Methicillin-Resistant Staphylococcus aureus (MRSA)

Planta Medica ◽  
2013 ◽  
Vol 79 (10) ◽  
Author(s):  
EW Ling Chan ◽  
JK Goh ◽  
SM Lee ◽  
AI Gray ◽  
JO Igoli
Keyword(s):  
Staphylococcus Aureus ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Antibacterial Activities ◽  
Flavonol Glycosides ◽  
Methicillin Resistant

scholarly journals Antibacterial of Cinnamon Bark (Cinnamomum burmannii) Essential Oil Against Methicillin-Resistant Staphylococcus aureus

2021 ◽  
Vol 4 (1) ◽  
pp. 56
Author(s):  
Shinta Levea Ni'matul Fadlilah ◽  
Mustofa Helmi Effendi ◽  
Wiwiek Tyasningsih ◽  
Lucia Tri Suwanti ◽  
Jola Rahmahani ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Essential Oil ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Antibacterial Activities ◽  
Diffusion Method ◽  
Disk Diffusion Method ◽  
Methicillin Resistant ◽  
Cinnamon Bark ◽  
Cinnamomum Burmannii

This study aimed to determine the in vitro antibacterial activities of essential oil from cinnamon bark (Cinnamomum burmannii) on Methicillin-resistant Staphylococcus aureus (MRSA) isolated from raw milk. Essential oil from cinnamon bark obtained from the steam distillation method and essential oil was made in a series dilution with a concentration of 1%, 2%, 4%, and 8%. The antibacterial activities were tested using the disk diffusion method. Results showed from five isolates of MRSA, one isolate was sensitive of essential oil with a concentration 2% and all of the isolate was sensitive with a concentration 4% and 8%. The antibacterial activity showed by inhibition zones on  MRSA. The results suggest that the activity of the essential oils of cinnamon bark has an antibacterial effect on MRSA and it is developed as phytopharmaca.

scholarly journals Antibacterial activity of endophytic fungi in Pometia pinnata against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus

2020 ◽  
Vol 21 (11) ◽  
Author(s):  
Ratna Setyaningsih ◽  
Ari Susilowati ◽  
Dina Prasetyani
Keyword(s):  
Staphylococcus Aureus ◽  
Antibacterial Activity ◽  
Medicinal Plants ◽  
Endophytic Fungi ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Its Region ◽  
Inhibition Zone ◽  
Antibacterial Activities ◽  
Bacterial Cells ◽  
Methicillin Resistant

Abstract. Endophytic fungi associated with medicinal plants are able to produce bioactive compounds which potentially contain medicinal ingredients. Matoa (Pometia pinnata J. R. Forst & G. Forst) is one of Indonesian medicinal plants. This research aims to test antibacterial activities of ethyl acetate extract of matoa’s endophytic fungi to Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus (MRSA) and also identify isolates having high antibacterial activity. Initial test on antibacterial activity was conducted by using paper disc diffusion, while advanced test was conducted by determining minimum inhibitory concentration (MIC). The fungi were identified in morphological and molecular manner with amplification and sequencing of ITS region. Bacterial cells exposed to the extract were observed by using scanning electron microscope (SEM). Isolate AM72 was found out to have the highest antibacterial activity compared to other 12 isolates tested, with inhibition zone diameter of 31.57 mm to S. aureus and 22.87 mm to MRSA. Isolate AM72 was identified as Lasiodiplodia theobromae. Isolate BMB identified as Aspergillus oryzae produced inhibition zone with 21.96 mm diameter to S. aureus and 21.50 mm diameter to MRSA. Advanced test to isolate AM72 gave the same MIC results to S. aureus and MRSA of 1.56%. Antibacterial compound produced by isolate AM72 were found out to be able to damage bacterial cell walls. Keywords: Antibacterial, Endohpytic Fungi, Matoa, S. aureus, MRSA  

scholarly journals Phytochemical analysis, antibacterial activity of hydromethanol extracts from stems of Ximenia americana, Côte d’Ivoire species on methicillin-resistant Staphylococcus aureus

2021 ◽  
Vol 14 (9) ◽  
pp. 3429-3440
Author(s):  
Baudelaire Affi Kakou ◽  
Anoubile Benie ◽  
Alain Hugues N’Guessan ◽  
Konan K. Fernique ◽  
N.K. Guessennd ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Antibacterial Activity ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Public Health Problem ◽  
Antibacterial Activities ◽  
Dilution Method ◽  
Phytochemical Analysis ◽  
Methicillin Resistant ◽  
Ximenia Americana

The emergence of bacteria resistant to several families of antibiotics is nowadays a public health problem in the world. To overcome this, it appeared necessary to explore sources of active molecules from natural substances. Thus, the objective of this study was to carry out the phytochemical sorting of hydromethanol extracts from Ximenia americana stems and to evaluate their antibacterial activities on the in-vitro growth of methicillin-resistant Staphylococcus aureus. The phytochemical screening performed allowed us to identify saponins, sterols and polyterpenes, polyphenols, tannins and flavonoids. HPLC-MS/MS analysis lead to the identification of a variety of flavan-3ol, quercetin and derivatives. The study of antibacterial activity carried out on 5 multi-resistant clinical strains and on a reference strain by the Muller-Hinton agar medium diffusion and dilution method showed that the extracts were active on all the strains with MICs ranging from 6.25 to 100 mg and MBCs ranging from 12.5 to 100 mg. The antibacterial potential of these extracts highlighted in this study could make this plant a candidate for in-depth investigations that could lead to the discovery of new antibacterial molecules. L’apparition de bactéries résistantes à plusieurs familles d’antibiotiques constitue, de nos jours, un problème de santé publique dans le monde. Pour y remédier, l’exploration de sources de molécules actives à partir des substances naturelles s’est avérée nécessaire. Ainsi, l’objectif de cette étude était de réaliser le tri phytochimique des extraits hydrométhanoliques de tiges de Ximenia americana et d’évaluer leurs activités antibactériennes sur la croissance in-vitro des Staphylococcus aureus résistant à la méticilline. Le screening phytochimique réalisé a permis d’identifier des saponines, des stérols et polyterpènes, des polyphénols, des tanins et des flavonoïdes. L’analyse à la HPLC-MS/MS a permis d’identifier une variété de flavan-3ol, de la quercétine et dérivées. L’étude de l’activité antibactérienne réalisée sur 5 souches cliniques multirésistantes et sur une souche de référence par la méthode de diffusion et de dilution en milieu gélosé Muller-Hinton a montré que les extraits étaient actifs sur toutes les souches avec des CMI variant de 6,25 à 100 mg et des CMB variant de 12,5 à 100 mg. Le potentiel antibactérien de ces extraits mis en évidence dans cette étude pourrait faire de cette plante une candidate à des investigations approfondies pouvant aboutir à la découverte de nouvelles molécules antibactériennes.

scholarly journals Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus.

1995 ◽  
Vol 39 (4) ◽  
pp. 910-916 ◽  
Author(s):  
Y Sumita ◽  
H Nouda ◽  
K Kanazawa ◽  
M Fukasawa
Keyword(s):  
Staphylococcus Aureus ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Inhibitory Concentration ◽  
Antibacterial Activities ◽  
Infection Model ◽  
Methicillin Resistant ◽  
Gram Positive Bacteria ◽  
Wide Range

The in vitro and in vivo antibacterial activities of SM-17466, a new 1 beta-methyl carbapenem, were evaluated against a wide range of clinical bacterial isoaltes and compared with the activities of meropenem, imipenem, vancomycin, and arbekacin. SM-17466 had a broad spectrum of action against gram-positive bacteria, showing especially potent activity against methicillin-resistant staphylococci. The MICs of SM-17466, meropenem, imipenem, vancomycin, and arbekacin at which 90% of clinical isolates of methicillin-resistant Staphylococcus aureus were inhibited were 3.13, 50, 100, 1.56, and 3.13 micrograms/ml, respectively. This activity of SM-17466 was almost equivalent to those of the antibiotics used for the treatment of infections caused by this organism. SM-17466 also showed bactericidal activity against methicillin-resistant S. aureus. In contrast, SM-17466 was less active against gram-negative bacteria, especially against Pseudomonas aeruginosa, compared with the other carbapenems; however, of the carbapenems, SM-17466 exhibited the highest activity against Haemophilus influenzae and Bacteriodes fragilis. SM-17466, at a 50% inhibitory concentration of less than 1 microgram/ml, bound to penicillin-binding proteins 1 to 4 in methicillin-susceptible S. aureus and also had good binding to penicillin-binding protein 2' in a methicillin-resistant strain (50% inhibitory concentration, 5.9 micrograms/ml). This high affinity, which was 10 and 20 times greater than those for meropenem and imipenem, respectively, was reflected in the potent activity of SM-17466 against methicillin-resistant S. aureus. SM-17466 demonstrated excellent in vivo efficacy against methicillin-susceptible and -resistant S. aureus strains in a mouse peritoneal infection model: the efficacy of SM-17466 against methicillin-resistant strains was equal to or one-third that of vancomycin. This activity was comparable to the in vitro activity of SM-17466. The subcutaneous injection of SM-17466 in mice revealed that the half-life of SM-17466 in serum was about 18 min, intermediate between those of vancomycin and arbekacin and 1.5-fold that of imipenem-cilastatin. SM-17466 was resistant to hydrolysis by swine renal dehydropeptidase I, to an extent comparable to the resistance shown by meropenem.

Sign in / Sign up

Export Citation Format

Share Document